Evidence map›Paper›PMID 28357376›Full record

ReviewMicrobial cell (Graz, Austria)2016

Gonorrhea - an evolving disease of the new millennium.

Stuart A Hill, Thao L Masters, Jenny Wachter

Abstract readReview
In one paragraph

Review in Microbial cell (Graz, Austria), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Global epidemiology ofSexually transmitted infections · 2021
    Pooled it
  2. Antibiotics for treating gonorrhoea in pregnancy.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Trial
  4. Small-Molecule Drugs Approved by the FDA in 2025.Molecules (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Low Oxygen Concentration ReducesAntibiotics (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Rolling the evolutionary dice:Microbiology spectrum · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Tolerance to Ceftriaxone inAntibiotics (Basel, Switzerland) · 2022
    Article
  18. National surveillance ofJAC-antimicrobial resistance · 2022
    Article
  19. Multiple pathogens and prostate cancer.Infectious agents and cancer · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stuart A HillDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7435.
Thao L MastersDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7435.
Jenny WachterDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7435.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Etiology, transmission and protection:

Indexed as

antibiotic resistanceantigenic variationimmune manipulationpanmicticpathogenesis

Identifiers

PMID28357376
PMCPMC5354566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.